Edgewise Therapeutics (NasdaqGS:EWTX) FY Conference January 13, 2026 11:15 AM ET Company ParticipantsKevin Koch - CEOConference Call ParticipantsTessa Romero - Biotechnology Equity AnalystTessa RomeroWelcome, everyone, to the 44th Annual J.P. Morgan Healthcare Conference. My name is Tess Romero, and I'm one of the Senior Biotech Analysts here at J.P. Morgan. Our next presenting company is Edgewise Therapeutics, and presenting on behalf of the company, we have President and CEO Kevin Koch. Kevin, over to you ...